Abel Hall LLC’s Lyra Therapeutics LYRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-244	Closed	-$1.54K	–	308
2025 Q1	$1.54K	Sell	244 -109	-31%	-$689	﹤0.01%	202
2024 Q4	$3.64K	Buy	+353	New	+$3.64K	﹤0.01%	165